Your treatment matters. Here’s why joining a diabetes clinical trial might be worth considering 2 April 2026 Paid partnership with Canopy Clinical Research Clinical trials are the reason most of today’s treatments exist. Trials help researchers discover better ways to prevent, manage, and treat conditions like diabetes, and they can also offer real benefits to participants. The first insulin trials in the 1920s transformed a once‑fatal diagnosis into a manageable condition. Later studies introduced metformin, and more recent trials paved the way for continuous glucose monitoring and insulin pumps. There are several reasons you might consider participating in a study. Why participate in a clinical trial? Access to enhanced monitoring and health assessments When you join a clinical trial, you are supported by a dedicated medical team who will follow your progress throughout the study. Clinical trials involve regular check-ins, health assessments, and opportunities to speak with the clinical research team about how you are managing your diabetes. New treatment options Clinical trials will often be exploring the effectiveness of new medications or devices that aren’t yet available to the public. For example, Canopy Clinical Research is currently conducting a study investigating a new medication for weight management in type 2 diabetes, as well as a diabetic foot ulcer trial which is investigating a new topical treatment designed to support healing. Your participation can help improve care for the wider diabetes community By taking part in a clinical trial, you can join a community of participants who are shaping history and the next generation of diabetes therapies. How to get involved? If you choose to register your interest in a clinical trial, the process usually begins with a brief pre‑screening call to discuss your health and diabetes history. This is followed by a clinic visit where you can meet the research team and ask any questions you may have. Learn more
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading
Blog 8 July 2026 Living Out Loud: why we’re asking 2 million Australians to speak up this National Diabetes Week People living with diabetes spend a lot of their lives explaining themselves to a world full of assumptions. This National... Continue Reading
Blog 8 July 2026 Taking the community’s voice to a global stage: IDF Western Pacific Region Congress 2026 This National Diabetes Week, we’re looking ahead to a landmark moment for our community, one that will see the voices,... Continue Reading